Search
for

    Sort by

    Research 571–600 of 1000+

    1. How actual is the treatment with antiandrogen alone in patients with polycystic ovary syndrome? Journal of endocrinological investigation · 1998 · 6 citations
    2. Nutritional Disorders of the Hair and Their Management 2020 · 5 citations
    3. Are Women with Polycystic Ovary Syndrome at Increased Risk of Alzheimer Disease? Lessons from Insulin Resistance, Tryptophan and Gonadotropin Disturbances and Their Link with Amyloid-Beta Aggregation Biomolecules · 2024 · 4 citations
    4. Bariatric surgery for spontaneous ovulation in women living with polycystic ovary syndrome: the BAMBINI multicentre, open-label, randomised controlled trial The Lancet · 2024 · 4 citations
    5. Androgens/Androgen Receptor in the Management of Skin Diseases Journal of Biosciences and Medicines · 2022 · 1 citations
    6. Prolonged use of finasteride-induced gonadal sex steroids alterations, DNA damage and menstrual bleeding in women Bioscience Reports · 2020 · 1 citations
    7. 5α-Reductase Isoenzymes: From Neurosteroid Biosynthesis to Neuropsychiatric Outcomes NeuroSci · 2026
    8. Green and Emerging Microextraction Strategies for Bioanalytical Determination of Hormones: Trends, Challenges, and Applications Molecules · 2025
    9. Technological Advances in Anti-hair Loss and Hair Regrowth Cosmeceuticals: Mechanistic Breakthroughs and Industrial Prospects Driven by Multidisciplinary Collaborative Innovation Aesthetic Plastic Surgery · 2025
    10. Immune and Non-immune Interactions in the Pathogenesis of Androgenetic Alopecia Clinical Reviews in Allergy & Immunology · 2025
    11. Causal Relationship Between Blood Metabolomics and Female Pattern Hair Loss: A Bidirectional Mendelian Randomization Study Clinical Cosmetic and Investigational Dermatology · 2025
    12. Ernährungsstörungen des Haares und deren Management 2025
    13. The Nutrient–Skin Connection: Diagnosing Eating Disorders Through Dermatologic Signs Nutrients · 2024
    14. Therapeutic potential of adult platelets and cord blood platelets in future clinical directions 2023
    15. Innovative Reports on the Effects of Anabolic Androgenic Steroid Abuse—How to Lose Your Mind for the Love of Sport Medicina-lithuania · 2023
    16. Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs Clinical, Cosmetic and Investigational Dermatology · 2023
    17. Platelet-rich Plasma and Its Application in Clinical Trial VNU Journal of Science: Medical and Pharmaceutical Sciences · 2021
    18. Androgens’ Effects across the Lifespan in Men and Animal Models IntechOpen eBooks · 2021
    19. Acanthosis nigricans, insulin resistance and cutaneous virilism 1988
    20. Male-pattern hair loss: Comprehensive identification of the associated genes as a basis for understanding pathophysiology Medizinische Genetik · 2023
    21. Prevalence of the metabolic syndrome in African populations: A systematic review and meta-analysis PLoS ONE · 2023 · 59 citations
    22. SARS-CoV-2 Infection and Alpha-Synucleinopathies: Potential Links and Underlying Mechanisms International Journal of Molecular Sciences · 2024 · 4 citations
    23. Prevalence of alopecia and its contributing factors among primary healthcare attendees in the Jazan region, Saudi Arabia Journal of family medicine and primary care · 2021 · 4 citations
    24. Investigating the Genetic Association of Selected Candidate Loci with Alopecia Areata Susceptibility in Jordanian Patients Medicina · 2025 · 1 citations
    25. The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia The New England Journal of Medicine · 2003 · 1707 citations
    26. Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor 2004 · 408 citations
    27. DIHYDROTESTOSTERONE AND THE PROSTATE: THE SCIENTIFIC RATIONALE FOR 5α-REDUCTASE INHIBITORS IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA 2004 · 235 citations
    28. Three-Month Treatment With a Long-Acting Gonadotropin-Releasing Hormone Agonist of Patients With Benign Prostatic Hyperplasia: Effects on Tissue Androgen Concentration, 5<i>α</i>-Reductase Activity and Androgen Receptor Content* 1989 · 82 citations
    29. BENIGN PREMATURE ADRENARCHE: CLINICAL FEATURES AND SERUM STEROID LEVELS Acta Paediatrica · 1983 · 77 citations
    30. Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology The BMJ · 2013 · 70 citations